PDCD1 and neoplasm: Moreover, radiotherapy can increase tumor PD-L1 expression, MHC I expression, exhaustion of CD8+ T cells and changes in the tumor microenvironment, which may enhance the resistance to anti-CTLA-4 and anti-PD-L1/PD-1 [80].